Main Menu
Search

28 June 2016

Globe with stethoscope

‘One-stop shop’

Asia’s medical technology start-ups get new fast track to market via partnership between Cambridge Consultants and Clearbridge Accelerator

Product design and development company Cambridge Consultants is teaming up with Singapore incubation firm Clearbridge Accelerator to create a ‘one-stop shop’ for medical technology start-ups in the region. The aim is to fast-track the commercialisation of innovative ideas, ranging from breakthrough diagnostic and surgical technology to cutting-edge connected devices.

The two organisations have signed a memorandum of understanding to establish a new way for start-ups to get to market quickly with minimised risk. Cambridge Consultants is providing product development services – acting as a virtual research and development centre to accelerate the transformation of ideas into commercial technology.

Clearbridge Accelerator is offering mentorship by seasoned entrepreneurs and advice on strategic, regulatory and operational issues. It is also providing financial guidance and access to funding across the whole spectrum, from seed/series A funding all the way to pre-IPO financing. The pre-IPO financing is being done through CapBridge – a private institutional venture exchange formed as a partnership between Clearbridge Accelerator and Singapore Exchange to assist high-growth companies globally.

Some of the biggest hurdles faced by medical technology start-ups are the availability of funding, and ready access to product development and regulatory expertise to convert an innovative idea into a commercial product ready for the market.

“Our extensive track record of world-class product development enables us to offer a rapid, reliable route to convert early-stage technology into ready-for-market solutions,” said Dr Miles Upton, Asia general manager at Cambridge Consultants. “For more than 50 years we have worked with innovative start-ups that want to change the status quo fast – helping them create world firsts that deliver real value. This collaboration with Clearbridge Accelerator will give new companies in the region a fast track to vital competitive edge.

“We have all the in-house skills needed to help clients take an innovative concept right the way through to manufacturing of a commercial product. Our bespoke teams of experts – in everything from human factors and industrial design to electronics, software, signal processing and algorithms – specialise in tackling tough challenges and helping clients achieve the seemingly impossible.”

Clearbridge Accelerator invests in game-changing technology companies with a focus on healthcare. It has a strong track record of leading early-stage investments, partnering with visionary entrepreneurs and world-leading institutions. Its team consists of serial entrepreneurs with deep domain expertise, extensive networks and operational experience in key markets such as the US, China, Japan and Australia.

“We invest in breakthrough innovations and technologies that will have global impact and benefits,” said Johnson Chen, managing partner at Clearbridge Accelerator. “As an incubator, besides providing direct expertise and funding, we constantly find new ways to help our start-up companies succeed.

“Through our partnership with Cambridge Consultants, companies can tap into the virtual development model to de-risk product development as well as get to market quickly. We are committed to growing Asian companies globally, as well as supporting international companies entering key Asian markets.”

The new initiative has been welcomed by enterprise development agency SPRING Singapore. “Singapore’s medical technology industry continues to show high potential for growth, with start-ups playing a crucial role in sustaining the vibrancy of the industry,” said Johnny Teo, director for investments, manufacturing & engineering at SPRING Singapore. “The collaboration between Clearbridge Accelerator and Cambridge Consultants is a move well received by the start-up community in Singapore. It resonates with the government’s efforts in catalysing more disruptive innovations from start-ups in deep-technology areas including medical technology.”

Notes to editors

Cambridge Consultants develops breakthrough products, creates and licenses intellectual property, and provides business consultancy in technology-critical issues for clients worldwide. For more than 50 years, the company has been helping its clients turn business opportunities into commercial successes, whether they are launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies. With a team of more than 700 staff, including engineers, scientists, mathematicians and designers, in offices in Cambridge (UK), Boston (USA) and Singapore, Cambridge Consultants offers solutions across a diverse range of industries including medical technology, industrial and consumer products, digital health, oil and gas, and wireless communications.

Cambridge Consultants is part of Altran, a global leader in engineering and R&D services which offers its clients a new way to innovate. Altran works alongside its clients on every link in the value chain of their project, from conception to industrialisation. In 2015, the Altran group generated revenues of €1.945bn. With a headcount of more than 27,000 employees, Altran is present in more than 20 countries. For more information, visit www.altran.com.

Clearbridge Accelerator is one of Singapore’s leading incubation and investment firms that invests in global deep-technology companies with a focus on healthcare and infosecurity. The company has developed an end-to-end commercialisation ecosystem from inception to exit, leveraging on its network of strategic partnerships and the CapBridge platform. Clearbridge Accelerator brings necessary funding, mentorship, operational and execution discipline to deliver determined and accelerated results. The company has an experienced team with strong expertise in scientific, operational and financial aspects. Clearbridge Accelerator is committed to grow Asian companies globally, and to support international companies entering key Asian markets.

Clearbridge Accelerator is supported by the National Research Foundation’s Technology Incubation Scheme and also manages a S$40 million fund for medical technology start-up companies under SPRING Singapore’s Biomedical Sciences Accelerator (BSA) programme. For more information, visit: www.clearbridgeaccelerator.com

Press Contacts

Corporate communications
Debbie Mayhew
PR & Communications Manager
Cambridge Consultants
+44 1223 392418
Debbie.Mayhew@CambridgeConsultants.com

European PR agency
David Vindel
Ketchum
+44 20 3755 6444
CambridgeConsultants@ketchum.com

US PR agency
Hanah Johnson
March Communications
+1 617 960 8892
CambridgeConsultants@ketchum.com